A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis

Inclusion Criteria: * Adult subjects 18-65 years of age * Diagnosis of atopic dermatitis (AD) * AD affecting at least 5% of total Body Surface Area (BSA) for Part 1 and at least 10% BSA for Part 2, not including face, neck, and head * Have had a positive but inadequate response to one or more treatment course of standard AD therapy including topical steroids, UV light A, narrowband UV B, and UV light B. Exclusion Criteria: -Use of systemic or topical therapy for contact or atopic dermatitis within 30 days of screening